Project Number 5R01AG066707-02 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for AlzheimerÂ’s Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions Researcher and Organization Principal Investigator CHENG, FEIXIONG Principal Investigator First Name FEIXIONG Principal Investigator Last Name CHENG Awardee Organization CLEVELAND CLINIC LERNER COM-CWRU Awardee State Ohio Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-17-032: Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01) FY Overall Cost $663,720 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YUAN, JEAN